| Mrs Lillian Lorraine Dubard, CFNP | |
|
965 Avent Dr, Suite 107, Grenada, MS 38901-5045 | |
| (662) 227-7575 | |
| (662) 227-6575 |
| Full Name | Mrs Lillian Lorraine Dubard |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 20 Years |
| Location | 965 Avent Dr, Grenada, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558382358 | NPI | - | NPPES |
| 02654890 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | R713066 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Mississippi Medical Center- Grenada | Grenada, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grenada Emergency Group, Llc | 2163854225 | 21 |
News Archive
Sodexo Inc., a world leader in healthcare environmental services management, and Xenex Healthcare Services, the world leader in room disinfection systems, today announced Xenex has been selected as Sodexo's preferred partner for disinfection of Sodexo client facilities. Xenex's portable room disinfection system uses pulsed xenon ultraviolet light to destroy all viruses, bacteria and bacterial spores in the patient environment without contact or chemicals.
Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.
The first three months of sobriety pose the greatest risk for relapse, and the greatest challenge for intervention efforts.
Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumor size.
› Verified 5 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
Sodexo Inc., a world leader in healthcare environmental services management, and Xenex Healthcare Services, the world leader in room disinfection systems, today announced Xenex has been selected as Sodexo's preferred partner for disinfection of Sodexo client facilities. Xenex's portable room disinfection system uses pulsed xenon ultraviolet light to destroy all viruses, bacteria and bacterial spores in the patient environment without contact or chemicals.
Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.
The first three months of sobriety pose the greatest risk for relapse, and the greatest challenge for intervention efforts.
Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumor size.
› Verified 5 days ago
| Entity Name | Grenada Emergency Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194388082 PECOS PAC ID: 2163854225 Enrollment ID: O20191112001896 |
News Archive
Sodexo Inc., a world leader in healthcare environmental services management, and Xenex Healthcare Services, the world leader in room disinfection systems, today announced Xenex has been selected as Sodexo's preferred partner for disinfection of Sodexo client facilities. Xenex's portable room disinfection system uses pulsed xenon ultraviolet light to destroy all viruses, bacteria and bacterial spores in the patient environment without contact or chemicals.
Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.
The first three months of sobriety pose the greatest risk for relapse, and the greatest challenge for intervention efforts.
Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumor size.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lillian Lorraine Dubard, CFNP 965 Avent Dr, Suite 107, Grenada, MS 38901-5045 Ph: (662) 227-7575 | Mrs Lillian Lorraine Dubard, CFNP 965 Avent Dr, Suite 107, Grenada, MS 38901-5045 Ph: (662) 227-7575 |
News Archive
Sodexo Inc., a world leader in healthcare environmental services management, and Xenex Healthcare Services, the world leader in room disinfection systems, today announced Xenex has been selected as Sodexo's preferred partner for disinfection of Sodexo client facilities. Xenex's portable room disinfection system uses pulsed xenon ultraviolet light to destroy all viruses, bacteria and bacterial spores in the patient environment without contact or chemicals.
Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.
The first three months of sobriety pose the greatest risk for relapse, and the greatest challenge for intervention efforts.
Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumor size.
› Verified 5 days ago
Kelsey Marter Faulkner, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 965 Avent Dr, Grenada, MS 38901 Phone: 601-815-2005 | |
Mrs. Agnes Pamela Upchurch, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1350 Sunset Dr, Ste B, Grenada, MS 38901 Phone: 662-229-0669 Fax: 662-227-9929 | |
Courtney Bullard, AGNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1966 F S Hill Dr, Grenada, MS 38901 Phone: 662-688-1519 | |
Mrs. Ashley Nicole Woods, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 140 Broadfield Dr, Grenada, MS 38901 Phone: 662-809-2419 | |
Latia Monanette Butts, CFNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1300 Sunset Dr, Ste Q, Grenada, MS 38901 Phone: 662-349-2442 Fax: 662-349-8551 | |
Shonda Jacqueline Phelon, C.F.N.P.; P.M.H.N.P Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1970 Grandview Dr, Grenada, MS 38901 Phone: 662-227-3700 Fax: 662-227-3740 | |
Alison Campbell, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1117 Sunset Dr Ste 104, Grenada, MS 38901 Phone: 662-226-0110 |